The combination therapy increased the infiltration of CD8+ T cells, and the percentages of IFNγ+, TNFα+ CD8+ T cells and the percentages of IFNγ+, TNFα+ CD4+ T cells in the tumor microenvironment (Fig. 6n). This evidence concerns the gene CD8A and neoplasm.